Skip to content

Annexon ANNX Short-Term Investments

Short-Term Investments at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.79B+10.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$483.59M+91.1%
Vor Biopharma logo
Vor BiopharmaVOR
$321.65M+3,120%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$276.8M+21.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$419.03M+133%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$37.99M-84.3%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's short-term investments?
Annexon (ANNX) reported short-term investments of $49.82M in Q1 2026.
How has Annexon's short-term investments changed year-over-year?
Annexon's short-term investments decreased by 70.1% year-over-year, from $166.57M to $49.82M.
What is the long-term trend for Annexon's short-term investments?
Over 5 years (2020 to 2025), Annexon's short-term investments has grown at a -1.6% compound annual growth rate (CAGR), from $82.64M to $76.29M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.